Hemostatics Concept

subject area of

• A Study of Safety and Effectiveness of Evicel Fibrin Sealant as an Adjunctive Hemostat in Pediatric Surgery  Journal Articles
• A comparison of methods for prediction of pharmacokinetics when switching to extended half-life products in hemophilia A patients  Journal Articles
• A new tool to assess bleeding severity in patients with chemotherapy‐induced thrombocytopenia (CME)  Journal Articles
• A prospective surveillance study of factor VIII inhibitor development in the Canadian haemophilia A population following the switch to a recombinant factor VIII product formulated with sucrose  Journal Articles
• A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins  Journal Articles
• A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery  Journal Articles
• APPLICATION OF NOVEL HEMOSTATIC AGENT DURING LAPAROSCOPIC PARTIAL NEPHRECTOMY  Journal Articles
• Acute management of bleeding in patients on novel oral anticoagulants  Journal Articles
• Acute reversal of anticoagulant-induced bleeding complications.  Journal Articles
• Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis  Journal Articles
• Bleeding and antidotes in new oral anticoagulants  Journal Articles
• Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency  Journal Articles
• Bleeding events in people with congenital haemophilia A without factor VIII inhibitors receiving prophylactic factor VIII treatment: A systematic literature review  Journal Articles
• Comparative pharmacokinetics of two extended half‐life FVIII concentrates (Eloctate and Adynovate) in adolescents with hemophilia A: Is there a difference?  Journal Articles
• Comparison of single subject and population‐based pharmacokinetics for optimizing prophylaxis with simoctocog alfa in patients with haemophilia A  Journal Articles
• Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII  Journal Articles
• Definition of haemostatic effectiveness in interventions used to treat major bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation  Journal Articles
• Effect of anti-fibrinolytic therapy on experimental melanoma metastasis  Journal Articles
• Effect of desmopressin on hematoma expansion in antiplatelet-associated intracerebral hemorrhage: A systematic review and meta-analysis  Journal Articles
• Effects of Cathepsin G Pretreatment of Platelets on their Subsequent Responses to Aggregating Agents  Journal Articles
• Efficacy of parenteral formulations of desmopressin in the treatment of bleeding disorders: A systematic review  Journal Articles
• Evaluation of safety and effectiveness of factor VIII treatment in haemophilia A patients with low titre inhibitors or a personal history of inhibitor  Journal Articles
• Feasibility of Using Recombinant Factor VIIa in Continuous Infusion  Journal Articles
• Fibrin Sealant in Surgery of Patients with a Hemorrhagic Diathesis  Conferences
• Fibrin and Thrombin Sealants in Vascular and Cardiac Surgery: A Systematic Review and Meta-analysis  Journal Articles
• Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa Inhibitors  Journal Articles
• Four-Factor Prothrombin Complex Concentrate for Urgent Reversal of Vitamin K Antagonists in Patients With Major Bleeding  Journal Articles
• Haemostatic and replacement therapy in von Willebrand disease  Journal Articles
• Healthcare resource utilization in patients receiving idarucizumab for reversal of dabigatran anticoagulation due to major bleeding, urgent surgery, or procedural interventions: interim results from the RE-VERSE AD™ study  Journal Articles
• Hemostatic management of von Willebrand disease during childbirth with a plasma-derived von Willebrand factor/factor VIII concentrate  Journal Articles
• How I treat target-specific oral anticoagulant–associated bleeding  Journal Articles
• Identification of hemostatic markers that define the pre‐DIC state: A multi‐center observational study  Journal Articles
• Immune Responses Associated With Perioperative Exposure and Reexposure to Topical Bovine Thrombin Do Not Impair Hemostasis  Journal Articles
• Impact of cardiopulmonary bypass duration on efficacy of fibrinogen replacement with cryoprecipitate compared with fibrinogen concentrate: a post hoc analysis of the Fibrinogen Replenishment in Surgery (FIBRES) randomised controlled trial  Journal Articles
• Management of Inheritedvon Willebrand Disease in Italy: Results from the Retrospective Study on 1234 Patients  Journal Articles
• Management of bleeding with oral anticoagulants in patients with atrial fibrillation  Journal Articles
• Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH  Journal Articles
• Managing bleeding in anticoagulated patients with a focus on novel therapeutic agents  Conferences
• Massive hemorrhage protocol survey: Marked variability and absent in one-third of hospitals in Ontario, Canada  Journal Articles
• Metaanalysis of prophylactic drug treatment in the prevention of postoperative bleeding  Journal Articles
• NXY‐059 Does Not Affect Bleeding Time in Healthy Volunteers: A Randomized, Double‐Blind, Placebo‐Controlled, 3‐Period Crossover Phase I Study  Journal Articles
• New Anti-thrombotic Agents: Emphasis on Hemorrhagic Complications and Their Management  Conferences
• Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report)  Journal Articles
• Outcomes for studies assessing the efficacy of hemostatic therapies in persons with congenital bleeding disorders  Journal Articles
• Pharmacokinetics and the transition to extended half‐life factor concentrates: communication from the SSC of the ISTH  Journal Articles
• Plasma-derived biological medicines used to promote haemostasis  Journal Articles
• Pre-Procedure Desmopressin Acetate to Reduce Bleeding in Renal Failure: Does It Really Work?  Journal Articles
• Prehospital Freeze-Dried Plasma in Trauma: A Critical Review  Journal Articles
• Prophylactic efficacy and pharmacokinetically guided dosing of a von Willebrand factor/factor VIII concentrate in adults and children with von Willebrand's disease undergoing elective surgery: a pooled and comparative analysis of data from USA and European Union clinical trials.  Journal Articles
• Prothrombin complex concentrate for reversal of direct factor Xa inhibitors prior to emergency surgery or invasive procedure: a retrospective study  Journal Articles
• Protocol for a multicentre, randomised, parallel-control, superiority trial comparing administration of clotting factor concentrates with a standard massive haemorrhage protocol in severely bleeding trauma patients: the FiiRST 2 trial (a 2020 EAST multicentre trial)  Journal Articles
• Randomized Study of Aprotinin Effect on Transfusions and Blood Loss in Primary THA  Journal Articles
• Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse  Journal Articles
• Recent Advances in Antidotes for Direct Oral Anticoagulants: Their Arrival Is Imminent  Journal Articles
• Recommended primary outcomes for clinical trials evaluating hemostatic blood products and agents in patients with bleeding: Proceedings of a National Heart Lung and Blood Institute and US Department of Defense Consensus Conference  Journal Articles
• Recurrence of Dialysis Shunt Pseudoaneurysm Following Percutaneous Thrombin Embolization  Journal Articles
• Retention of hemostatic and immunological properties of frozen plasma and COVID‐19 convalescent apheresis fresh‐frozen plasma produced and freeze‐dried in Canada  Journal Articles
• Reversal of the Anticoagulant Effects of Warfarin by Vitamin K1  Journal Articles
• Supplemental fibrinogen restores thrombus formation in cardiopulmonary bypass-induced platelet dysfunction ex vivo  Journal Articles
• Tailoring treatment of haemophilia B: accounting for the distribution and clearance of standard and extended half-life FIX concentrates  Journal Articles
• The temporal changes of hemostatic activity in hospitalized patients with COVID-19: a prospective observational study  Journal Articles
• The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A  Journal Articles
• There may be no differences in the success of periapical surgery when using aluminum chloride or epinephrine as hemostatic agent during surgery  Journal Articles
• There seem to be no differences in the hemostatic efficacy between aluminum chloride and electrocauterization in patients undergoing periapical surgery  Journal Articles
• Thrombin generation, bleeding and hemostasis in humans: Protocol for a scoping review of the literature  Journal Articles
• Thromboelastometry reveals similar hemostatic properties of purified fibrinogen and a mixture of purified cryoprecipitate protein components  Journal Articles
• Time Course of Early Hematoma Expansion in Acute Spot-Sign Positive Intracerebral Hemorrhage: Prespecified Analysis of the SPOTLIGHT Randomized Clinical Trial  Journal Articles
• Topical application of antifibrinolytic drugs for on-pump cardiac surgery: a systematic review and meta-analysis  Journal Articles
• Understanding FVIII/VWF complex – report from a symposium of XXIX WFH meeting 2010  Journal Articles
• Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A  Journal Articles
• Venous and arterial thrombosis in COVID-19: An updated narrative review  Journal Articles
• What can ex vivo experiments contribute to clinical haemostasis management?  Journal Articles
• [New preparations for coagulation disorders].  Journal Articles